Parkland Center for Clinical Innovation (PCCI) Announces New Board Member
Building its strong Board to drive innovation in healthcare, PCCI appoints Michael Sachs, Chairman of TLSG, Inc.
Dallas, TX — Michael Sachs has been appointed to the Parkland Center for Clinical Innovation (PCCI) Board of Directors. Sachs is Chairman of TLSG, Inc, an investment advisory and consulting firm.
“I am very excited and honored that Michael is joining the PCCI Board. He is a top healthcare executive and visionary, and has been a personal mentor and role model for the last 15 years,” said Steve Miff, PhD, PCCI’s President and CEO. “His passion for transforming healthcare and his insights and guidance will help us expand PCCI’s innovation and impact.”
Sachs has spent his entire career in healthcare with a focus on developing data and information companies. He is working with startups and early stage companies in the healthcare, biomedical and data science fields. He began his career as a paramedic, served as an administrator at Hurley Medical Center in Flint, Michigan, and was a consultant at A.T. Kearney and Ernst and Whinney in Chicago.
Sachs earned a Master of Science in Public Health and a Bachelor of Science degrees from the University of Missouri, Columbia. He is active with a number of community organizations including hospitals in Jupiter, Florida, Los Angeles and Chicago. He serves on numerous Boards of Directors of private companies as well as the Board of Directors of The Ounce of Prevention in Chicago.
“I am honored to be able to support PCCI’s mission of improving the delivery of healthcare services to a diverse population through applying innovative techniques of data analysis and precision medicine, “ Sachs said. “The track record of PCCI’s innovations are leading to better delivery of services in Dallas and beyond, a true learning lab for US healthcare. The team led by Dr. Miff is exceptional and recognized by its peers to be one of the best in the nation. I look forward to helping to grow PCCI’s valuable work.”
Sachs joins PCCI’s Board of Directors which includes:
Fred Cerise, MD, President and CEO, Parkland Health & Hospital Systems
Steve Miff, PhD, President and CEO, Parkland Center for Clinical Innovation
Winfred Parnell, MD, an OBGYN and Chair of the Board of Managers at Parkland
Ted Shaw, President and CEO, Texas Hospital Association
Bob Smith, Healthcare Consultant
Ted Shaw, Chairman of the PCCI Board added, “Michael will be a great addition to the PCCI Board. His experience in data analytics and decades of experience serving the healthcare community will be of great value.”
PCCI is an independent, not-for-profit healthcare intelligence organization focused on creating connected communities through data science and machine learning. Our teams combine deep clinical expertise with advanced analytics and artificial intelligence to enable the delivery of precision medicine at the point of care. PCCI is a recipient of more than $45 million in grants directed at developing and deploying patient centric cutting edge technologies connecting communities, Parkland and beyond.
Lindsey Nace, Marketing and Communications